1-4 of 4
Maren Mieth, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Induction of CXCL1 in Osteoblasts by Myeloma Cells Promotes Migration of Osteoclast Precursors

Martin F. Kaiser, MD, Ulrike Heider, MD, Maren Mieth, PhD, Jozef Zustin, MD, Andrea Kuehnl, MD, Ivana von Metzler, MD, Orhan Sezer, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 441.
https://doi.org/10.1182/blood.V120.21.441.441
Published: 2012
Journal Articles

An Angiogenic Risk Score Improves the Prognostic Information of the International Staging System in Patients with Symptomatic Multiple Myeloma.

Christian Jakob, MD,, Theresa Wernecke, MD, Jan Sterz, MD, Andrea Goerke, MD, Ulrike Heider, MD, Martin Kaiser, MD, Maren Mieth, PhD, Susanne Ziefle, MD, Orhan Sezer, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2802.
https://doi.org/10.1182/blood.V114.22.2802.2802
Published: 2009
Journal Articles

Serum Concentrations of DKK-1 Correlate with the Extent of Bone Disease in Multiple Myeloma.

Martin Kaiser, MD, Maren Mieth, PhD, Peter Liebisch, MD, PhD, Susanne Rötzer, Christian Jakob, MD, Claudia Fleissner, MD, Edgar Braendle, MD, PhD, David Stover, PhD, Malte Peters, MD, PhD, Orhan Sezer, MD, PhD, Ulrike Heider, MD
Journal: Blood
Blood (2007) 110 (11): 3518.
https://doi.org/10.1182/blood.V110.11.3518.3518
Published: 2007
Journal Articles

Bortezomib Inhibits Human Osteoclastogenesis.

Ivana Zavrski, MD, Monica Hecht, PhD, Holger Krebbel, Claudia Fleissner, MD, Maren Mieth, PhD, Martin Kaiser, MD, Ulrike Heider, MD, Christian Jakob, MD, Jan Sterz, Kurt Possinger, MD, Orhan Sezer, MD
Journal: Blood
Blood (2006) 108 (11): 1395.
https://doi.org/10.1182/blood.V108.11.1395.1395
Published: 2006